| Lauren Elizabeth Bostwick, PHYSICIAN ASSISTANT | |
|
901 Von Kolnitz Rd Ste 100, Mt Pleasant, SC 29464-3772 | |
| (843) 216-3376 | |
| Not Available |
| Full Name | Lauren Elizabeth Bostwick |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Location | 901 Von Kolnitz Rd Ste 100, Mt Pleasant, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942085915 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207NS0135X | Dermatology - Procedural Dermatology | 1201326 (South Carolina) | Secondary |
| 207N00000X | Dermatology | 1201326 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lauren Elizabeth Bostwick, PHYSICIAN ASSISTANT 901 Von Kolnitz Rd Ste 100, Mt Pleasant, SC 29464-3772 Ph: (843) 216-3376 | Lauren Elizabeth Bostwick, PHYSICIAN ASSISTANT 901 Von Kolnitz Rd Ste 100, Mt Pleasant, SC 29464-3772 Ph: (843) 216-3376 |
News Archive
Preterm babies born early in the third trimester of pregnancy are likely to experience delays in the development of the auditory cortex, a brain region essential to hearing and understanding sound, a new study reveals.
The antiepileptic drug vigabatrin (VGB) has been shown to be one of the best treatments against a special form of epilepsy in infants, called infantile spasm.
Cempra Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases,today announced that data will be presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), in London, March 31 to April 3,demonstrating CEM-101's (solithromycin's) efficacy to be comparable to levofloxacin in a Phase 2 trial of patients with community-acquired bacterial infections.
EnVivo Pharmaceuticals today announced the initiation and dosing of patients in a Phase 2b study of its EVP-6124 compound, a selective alpha-7 nicotinic agonist in patients with schizophrenia. EnVivo is conducting the multi-center, dose ranging, placebo controlled, three-month study in the U.S. and Europe.
A new test for identifying a mismatch between the blood of a pregnant woman and her baby is accurate, feasible, and could substantially reduce unnecessary treatment, finds a Bristol study published on bmj.com.
› Verified 4 days ago
Caroline Felder Wooten, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 570 Long Point Rd Ste 200, Mt Pleasant, SC 29464 Phone: 843-881-0320 Fax: 843-881-5453 | |
Dr. Taylor Benoit Mulkey, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 612 Seacoast Pkwy, Mt Pleasant, SC 29464 Phone: 843-881-4440 Fax: 843-225-0110 | |
Dr. Michele A Mittelbronn, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 999 Lake Hunter Cir, Suite B, Mt Pleasant, SC 29464 Phone: 843-881-2265 Fax: 843-881-2789 | |
Dr. Jennifer Anne Steele, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 570 Long Point Rd, Suite 200, Mt Pleasant, SC 29464 Phone: 843-881-0320 Fax: 843-881-5453 |